Aker Biomarine AS (Oslo, Norway) is now the newest member of the Global Organization for EPA and DHA Omega-3.
Aker Biomarine AS (Oslo, Norway) is now the newest member of the Global Organization for EPA and DHA Omega-3 (GOED; Salt Lake City).
Aker’s new membership means the krill oil manufacturer will comply with GOED’s collaborative efforts to support sustainable development of and education on the omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid).
"We appreciate that [Aker]will work inside GOED to contribute to the responsible growth and development of krill products with defined and transparent criteria and specifications that help enable consumer trust,” said GOED executive director Adam Ismail. “Krill oil is a growing and important source of EPA and DHA for consumers worldwide, so proactive quality initiatives driven by companies like [Aker]and other krill manufacturers will be important.”
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.